Medical Aesthetics Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,850	156 Pages	Fortune Business Insights Pvt. Ltd.	October, 2024	FOB19224164

Best Price Guarantee
Price	from $4,850
Length	156 Pages
Publisher	Fortune Business Insights Pvt. Ltd.
Published Date	October, 2024
SKU	FOB19224164

Medical Aesthetics Market

Growth Factors of Medical Aesthetics Market

The medical aesthetics market size was valued at USD 22.84 billion in 2023, and the market is now projected to grow from USD 25.48 billion in 2024 to USD 67.89 billion by 2032, exhibiting a CAGR of 13.0% during the forecast period of 2024-2032.

Trends indicate that there has been a decrease in cosmetic procedures across the world in the wake of the COVID-19 pandemic and the restrictions that resulted in the reduction in elective surgeries and the supply chain. However, with some of the restrictions eased in 2021 and embracing hybrid micro-needling, new specifications in medical aesthetics returned. It is expected that the growth in the market will begin to grow at a steady pace in the subsequent years.

Higher incidence rates of skin diseases including acne, psoriasis, and skin cancer are thus driving the need for improving treatment processes. As a result of the high demand for treatments to skin diseases, the market is boosted greatly by the presence of a large patient pool. The availability of such services and products indicates that there is always a gap for the development of new dermatological solutions.

People are getting more conscious to go in for simple procedures like botulinum toxin injections, dermal fillers, and chemical peels rather than surgeries. These include short time to recovery, low incidences of complications, faster resolutions, and high success rates that have encouraged adoption of non-invasive procedures. With this knowledge, the use of non-invasive surgeries will increasingly be widely adopted. This is changing the structure/format of the cosmetic treatments in a manner that is different from the formats we have seen in the past.

Comprehensive Analysis of Medical Aesthetics Market

The medical aesthetics market growth is rising at an exponential rate due to its market segmentation. This market expansion rightly provides a thorough market breakdown near to the industry considering the leading supply and demand forces. These segmentations are methodically segregated by type analysis, by application analysis, and by end-user analysis. By type analysis include energy-based devices, non-energy-based devices, and others. By application analysis include skin resurfacing & tightening, body contouring and cellulite reduction, hair and tattoo removal, breast augmentation, and others. By end-user analysis include hospitals, specialty clinics, and others.

The North America region lead the medical aesthetics market share by benefitting a market size of USD 12.28 billion in 2023 due to the increasing popularity of cosmetic procedures.

The top players in the markets have a central responsibility in the healthcare industry to be sure of industrial prospectus development and to establish the market norms. These players include, Sisram Medical Ltd, Merz Pharma, Apyx Medical, AbbVie Inc., El.En. S.p.A., Johnson & Johnson Services, Inc. (MENTOR), Candela Medical, Cutera, Bausch Health Companies Inc., Sientra, Inc. these market players provide a level-playing competitive landscape.

In November 2023, LUBEX launched the Sapphire ice-cooling hair removal device, designed for at-home use.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Growth Rate CAGR of 13.0% from 2024-2032

Unit Value (USD billion)

Segmentation By Type

Energy-based Aesthetic Devices
Laser-based Aesthetic Devices
Radiofrequency-based Aesthetic Devices
Light-based Aesthetic Devices
Ultrasound Aesthetic Devices
Non-energy-based Aesthetic Devices
Botulinum Toxin
Dermal Fillers
Microdermabrasion
Implants
Dental Implants
Breast Implants
Other Implants
Others

By Application

Skin Resurfacing & Tightening
Body Contouring and Cellulite Reduction
Hair and Tattoo Removal
Breast Augmentation
Other Applications

By End-user

Hospitals
Specialty Clinics
Others

By Region

North America (By Type, By Application, By End-user, and By Country)
U.S.
Canada
Europe (By Type, By Application, By End-user, and By Country/Sub-region)
Germany
U.K.
France
Italy
Spain
Scandinavia
Rest of Europe
Asia Pacific (By Type, By Application, By End-user, and By Country/Sub-region)
India
China
Japan
Australia
Southeast Asia
Rest of Asia Pacific
Latin America (By Type, By Application, By End-user, and By Country/Sub-region)
Brazil
Mexico
Rest of Latin America
Middle East & Africa (By Type, By Application, By End-user, and By Country/Sub-region)
GCC
South Africa
Rest of Middle East & Africa

Please Note: It will take 5-6 business days to complete the report upon order confirmation.

1. Introduction: 1.1. Research Scope; 1.2. Market Segmentation; 1.3. Research Methodology; 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics: 3.1. Market Drivers; 3.2. Market Restraints; 3.3. Market Opportunities; 3.4. Market Trends
4. Key Insights: 4.1. Total Number of Aesthetic Procedures- Invasive & Non-Invasive, By Key Countries, 2022/2023; 4.2. Technological Advancements in Medical Aesthetic Devices; 4.3. New Product Launches, By Key Players; 4.4. Key Industry Developments- Mergers, Partnerships, & Acquisitions; 4.5. Impact of COVID-19 on the Market
5. Global Medical Aesthetics Market Analysis, Insights and Forecast, 2019-2032: 5.1. Market Analysis, Insights and Forecast – By Type; 5.1.1. Energy-based Aesthetic Devices; 5.1.1.1. Laser-based Aesthetic Devices; 5.1.1.2. Radiofrequency based Aesthetic Devices; 5.1.1.3. Light-based Aesthetic Devices; 5.1.1.4. Ultrasound Aesthetic Devices; 5.1.2. Non-Energy based Aesthetic Devices; 5.1.2.1. Botulinum Toxin; 5.1.2.2. Dermal Fillers; 5.1.2.3. Microdermabrasion; 5.1.2.4. Implants; 5.1.2.4.1. Dental Implants; 5.1.2.4.2. Breast Implants; 5.1.2.4.3. Other Implants; 5.1.3. Other Aesthetic Devices; 5.2. Market Analysis, Insights and Forecast – By Application; 5.2.1. Skin Resurfacing & Tightening; 5.2.2. Body Contouring and Cellulite Reduction; 5.2.3. Hair and Tattoo Removal; 5.2.4. Breast Augmentation; 5.2.5. Other Applications; 5.3. Market Analysis, Insights and Forecast – By End-user; 5.3.1. Hospitals; 5.3.2. Specialty Clinics; 5.3.3. Others; 5.4. Market Analysis, Insights and Forecast – By Region; 5.4.1. North America; 5.4.2. Europe; 5.4.3. Asia Pacific; 5.4.4. Latin America; 5.4.5. Middle East & Africa
6. North America Medical Aesthetics Market Analysis, Insights and Forecast, 2019-2032: 6.1. Market Analysis, Insights and Forecast – By Type; 6.1.1. Energy-based Aesthetic Devices; 6.1.1.1. Laser-based Aesthetic Devices; 6.1.1.2. Radiofrequency based Aesthetic Devices; 6.1.1.3. Light-based Aesthetic Devices; 6.1.1.4. Ultrasound Aesthetic Devices; 6.1.2. Non-Energy based Aesthetic Devices; 6.1.2.1. Botulinum Toxin; 6.1.2.2. Dermal Fillers; 6.1.2.3. Microdermabrasion; 6.1.2.4. Implants; 6.1.2.4.1. Dental Implants; 6.1.2.4.2. Breast Implants; 6.1.2.4.3. Other Implants; 6.1.3. Other Aesthetic Devices; 6.2. Market Analysis, Insights and Forecast – By Application; 6.2.1. Skin Resurfacing & Tightening; 6.2.2. Body Contouring and Cellulite Reduction; 6.2.3. Hair and Tattoo Removal; 6.2.4. Breast Augmentation; 6.2.5. Other Applications; 6.3. Market Analysis, Insights and Forecast – By End-user; 6.3.1. Hospitals; 6.3.2. Specialty Clinics; 6.3.3. Others; 6.4. Market Analysis, Insights and Forecast – By Country; 6.4.1. U.S.; 6.4.2. Canada
7. Europe Medical Aesthetics Market Analysis, Insights and Forecast, 2019-2032: 7.1. Market Analysis, Insights and Forecast – By Type; 7.1.1. Energy-based Aesthetic Devices; 7.1.1.1. Laser-based Aesthetic Devices; 7.1.1.2. Radiofrequency based Aesthetic Devices; 7.1.1.3. Light-based Aesthetic Devices; 7.1.1.4. Ultrasound Aesthetic Devices; 7.1.2. Non-Energy based Aesthetic Devices; 7.1.2.1. Botulinum Toxin; 7.1.2.2. Dermal Fillers; 7.1.2.3. Microdermabrasion; 7.1.2.4. Implants; 7.1.2.4.1. Dental Implants; 7.1.2.4.2. Breast Implants; 7.1.2.4.3. Other Implants; 7.1.3. Other Aesthetic Devices; 7.2. Market Analysis, Insights and Forecast – By Application; 7.2.1. Skin Resurfacing & Tightening; 7.2.2. Body Contouring and Cellulite Reduction; 7.2.3. Hair and Tattoo Removal; 7.2.4. Breast Augmentation; 7.2.5. Other Applications; 7.3. Market Analysis, Insights and Forecast – By End-user; 7.3.1. Hospitals; 7.3.2. Specialty Clinics; 7.3.3. Others; 7.4. Market Analysis, Insights and Forecast – By Country/ Sub-region; 7.4.1. Germany; 7.4.2. U.K.; 7.4.3. France; 7.4.4. Italy; 7.4.5. Spain; 7.4.6. Scandinavia; 7.4.7. Rest of Europe
8. Asia Pacific Medical Aesthetics Market Analysis, Insights and Forecast, 2019-2032: 8.1. Market Analysis, Insights and Forecast – By Type; 8.1.1. Energy-based Aesthetic Devices; 8.1.1.1. Laser-based Aesthetic Devices; 8.1.1.2. Radiofrequency based Aesthetic Devices; 8.1.1.3. Light-based Aesthetic Devices; 8.1.1.4. Ultrasound Aesthetic Devices; 8.1.2. Non-Energy based Aesthetic Devices; 8.1.2.1. Botulinum Toxin; 8.1.2.2. Dermal Fillers; 8.1.2.3. Microdermabrasion; 8.1.2.4. Implants; 8.1.2.4.1. Dental Implants; 8.1.2.4.2. Breast Implants; 8.1.2.4.3. Other Implants; 8.1.3. Other Aesthetic Devices; 8.2. Market Analysis, Insights and Forecast – By Application; 8.2.1. Skin Resurfacing & Tightening; 8.2.2. Body Contouring and Cellulite Reduction; 8.2.3. Hair and Tattoo Removal; 8.2.4. Breast Augmentation; 8.2.5. Other Applications; 8.3. Market Analysis, Insights and Forecast – By End-user; 8.3.1. Hospitals; 8.3.2. Specialty Clinics; 8.3.3. Others; 8.4. Market Analysis, Insights and Forecast – By Country/ Sub-region; 8.4.1. India; 8.4.2. China; 8.4.3. Japan; 8.4.4. Australia; 8.4.5. Southeast Asia; 8.4.6. Rest of Asia Pacific
9. Latin America Medical Aesthetics Market Analysis, Insights and Forecast, 2019-2032: 9.1. Market Analysis, Insights and Forecast – By Type; 9.1.1. Energy-based Aesthetic Devices; 9.1.1.1. Laser-based Aesthetic Devices; 9.1.1.2. Radiofrequency based Aesthetic Devices; 9.1.1.3. Light-based Aesthetic Devices; 9.1.1.4. Ultrasound Aesthetic Devices; 9.1.2. Non-Energy based Aesthetic Devices; 9.1.2.1. Botulinum Toxin; 9.1.2.2. Dermal Fillers; 9.1.2.3. Microdermabrasion; 9.1.2.4. Implants; 9.1.2.4.1. Dental Implants; 9.1.2.4.2. Breast Implants; 9.1.2.4.3. Other Implants; 9.1.3. Other Aesthetic Devices; 9.2. Market Analysis, Insights and Forecast – By Application; 9.2.1. Skin Resurfacing & Tightening; 9.2.2. Body Contouring and Cellulite Reduction; 9.2.3. Hair and Tattoo Removal; 9.2.4. Breast Augmentation; 9.2.5. Other Applications; 9.3. Market Analysis, Insights and Forecast – By End-user; 9.3.1. Hospitals; 9.3.2. Specialty Clinics; 9.3.3. Others; 9.4. Market Analysis, Insights and Forecast – By Country/ Sub-region; 9.4.1. Brazil; 9.4.2. Mexico; 9.4.3. Rest of Latin America
10. Middle East & Africa Medical Aesthetics Market Analysis, Insights and Forecast, 2019-2032: 10.1. Market Analysis, Insights and Forecast – By Type; 10.1.1. Energy-based Aesthetic Devices; 10.1.1.1. Laser-based Aesthetic Devices; 10.1.1.2. Radiofrequency based Aesthetic Devices; 10.1.1.3. Light-based Aesthetic Devices; 10.1.1.4. Ultrasound Aesthetic Devices; 10.1.2. Non-Energy based Aesthetic Devices; 10.1.2.1. Botulinum Toxin; 10.1.2.2. Dermal Fillers; 10.1.2.3. Microdermabrasion; 10.1.2.4. Implants; 10.1.2.4.1. Dental Implants; 10.1.2.4.2. Breast Implants; 10.1.2.4.3. Other Implants; 10.1.3. Other Aesthetic Devices; 10.2. Market Analysis, Insights and Forecast – By Application; 10.2.1. Skin Resurfacing & Tightening; 10.2.2. Body Contouring and Cellulite Reduction; 10.2.3. Hair and Tattoo Removal; 10.2.4. Breast Augmentation; 10.2.5. Other Applications; 10.3. Market Analysis, Insights and Forecast – By End-user; 10.3.1. Hospitals; 10.3.2. Specialty Clinics; 10.3.3. Others; 10.4. Market Analysis, Insights and Forecast – By Country/ Sub-region; 10.4.1. GCC; 10.4.2. South Africa; 10.4.3. Rest of Middle East & Africa
11. Competitive Analysis: 11.1. Global Market Share Analysis (2023); 11.2. Company Profiles; 11.2.1. Sisram Medical Ltd; 11.2.1.1. Overview; 11.2.1.2. Products & Services; 11.2.1.3. SWOT Analysis; 11.2.1.4. Recent Developments; 11.2.1.5. Strategies; 11.2.1.6. Financials (Based on Availability); 11.2.2. Merz Pharma; 11.2.2.1. Overview; 11.2.2.2. Products & Services; 11.2.2.3. SWOT Analysis; 11.2.2.4. Recent Developments; 11.2.2.5. Strategies; 11.2.2.6. Financials (Based on Availability); 11.2.3. Apyx Medical; 11.2.3.1. Overview; 11.2.3.2. Products & Services; 11.2.3.3. SWOT Analysis; 11.2.3.4. Recent Developments; 11.2.3.5. Strategies; 11.2.3.6. Financials (Based on Availability); 11.2.4. AbbVie Inc.; 11.2.4.1. Overview; 11.2.4.2. Products & Services; 11.2.4.3. SWOT Analysis; 11.2.4.4. Recent Developments; 11.2.4.5. Strategies; 11.2.4.6. Financials (Based on Availability); 11.2.5. El.En. S.p.A.; 11.2.5.1. Overview; 11.2.5.2. Products & Services; 11.2.5.3. SWOT Analysis; 11.2.5.4. Recent Developments; 11.2.5.5. Strategies; 11.2.5.6. Financials (Based on Availability); 11.2.6. Johnson & Johnson Services, Inc. (MENTOR); 11.2.6.1. Overview; 11.2.6.2. Products & Services; 11.2.6.3. SWOT Analysis; 11.2.6.4. Recent Developments; 11.2.6.5. Strategies; 11.2.6.6. Financials (Based on Availability); 11.2.7. Candela Medical; 11.2.7.1. Overview; 11.2.7.2. Products & Services; 11.2.7.3. SWOT Analysis; 11.2.7.4. Recent Developments; 11.2.7.5. Strategies; 11.2.7.6. Financials (Based on Availability); 11.2.8. Cutera; 11.2.8.1. Overview; 11.2.8.2. Products & Services; 11.2.8.3. SWOT Analysis; 11.2.8.4. Recent Developments; 11.2.8.5. Strategies; 11.2.8.6. Financials (Based on Availability); 11.2.9. Bausch Health Companies Inc.; 11.2.9.1. Overview; 11.2.9.2. Products & Services; 11.2.9.3. SWOT Analysis; 11.2.9.4. Recent Developments; 11.2.9.5. Strategies; 11.2.9.6. Financials (Based on Availability); 11.2.10. Sientra, Inc.; 11.2.10.1. Overview; 11.2.10.2. Products & Services; 11.2.10.3. SWOT Analysis; 11.2.10.4. Recent Developments; 11.2.10.5. Strategies; 11.2.10.6. Financials (Based on Availability)